| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |